Black Diamond Therapeutics
BDTX
BDTX
102 hedge funds and large institutions have $308M invested in Black Diamond Therapeutics in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 41 increasing their positions, 13 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
33% less call options, than puts
Call options by funds: $946K | Put options by funds: $1.42M
56% less capital invested
Capital invested by funds: $705M → $308M (-$397M)
Holders
102
Holding in Top 10
–
Calls
$946K
Puts
$1.42M
Top Buyers
| 1 | +$14.9M | |
| 2 | +$7.17M | |
| 3 | +$3.55M | |
| 4 |
SG Americas Securities
New York
|
+$3.36M |
| 5 |
BlackRock
New York
|
+$2.73M |
Top Sellers
| 1 | -$21.1M | |
| 2 | -$17.8M | |
| 3 | -$13.4M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$10.7M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$8.74M |